-+ 0.00%
-+ 0.00%
-+ 0.00%

Dermata Therapeutics FY2025 net loss narrows 38.48% to $(7.6) million; operating expenses drop 37.87% to $7.8 million

Reuters·03/26/2026 21:18:29

Please log in to view news